BlackRock, Inc. - 31 Mar 2025 SCHEDULE 13G/A Report for ULTRAGENYX PHARMACEUTICAL INC Common Stock (RARE)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: ULTRAGENYX PHARMACEUTICAL INC Common Stock
Symbol: RARE
Shares outstanding: 94,528,059 shares
Disclosed Ownership: 4,820,931 shares
Ownership: 5.1%
Form type: SCHEDULE 13G/A
Filing time: 24 Apr 2025, 09:12:39 UTC
Date of event: 31 Mar 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	5.1%	4,820,931	4,669,755	0	Spencer Fleming	Managing Director